<SEC-DOCUMENT>0001193125-19-078796-index.html : 20190319
<SEC-HEADER>0001193125-19-078796.hdr.sgml : 20190319
<ACCEPTANCE-DATETIME>20190319060230
ACCESSION NUMBER:		0001193125-19-078796
CONFORMED SUBMISSION TYPE:	NT 10-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20181231
FILED AS OF DATE:		20190319
DATE AS OF CHANGE:		20190319
EFFECTIVENESS DATE:		20190319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akebia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001517022
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				208756903
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		NT 10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36352
		FILM NUMBER:		19690108

	BUSINESS ADDRESS:	
		STREET 1:		245 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-871-2098

	MAIL ADDRESS:	
		STREET 1:		245 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-K
<SEQUENCE>1
<FILENAME>d627174dnt10k.htm
<DESCRIPTION>NT 10-K
<TEXT>
Document 1 - file: d627174dnt10k.htm

</DOCUMENT>
</SEC-DOCUMENT>